U
Sage Potash Corp. SAGE.V
TSX
Recommendation
Prev Close
$0.25
Volume
--
Avg Vol (90D)
108,640
Market Cap
$14.68M
Dividend & Yield
--
52-Week Range
$0.13 - $0.39
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
4/24/2025 - Zacks Investment Research
Can Biogen Keep the Beat Streak Alive This Earnings Season?
4/24/2025 - Zacks Investment Research
Sage Therapeutics (SAGE, $7.68) price moved above its 50-day Moving Average on April 22, 2025
4/23/2025 - Tickeron - Stocks
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Recommendation of "Hold" by Analysts
4/23/2025 - MarketBeat
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
4/22/2025 - GuruFocus
Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
4/22/2025 - PR Newswire
Sage Therapeutics (SAGE, $7.44) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 21, 2025
4/22/2025 - Tickeron - Stocks
Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
4/22/2025 - Zacks Investment Research
Morgan Stanley Keeps Their Hold Rating on SAGE Therapeutics (SAGE)
4/21/2025 - TipRanks Financial Blog
Q1 Earnings Forecast for SAGE Issued By Wedbush
4/19/2025 - MarketBeat
Sage Therapeutics (SAGE, $7.37) price exceeded its 50-day Moving Average on April 16, 2025
4/17/2025 - Tickeron - Stocks
Sage Therapeutics (SAGE, $7.54) price moved above its 50-day Moving Average on April 15, 2025
4/16/2025 - Tickeron - Technical Analysis
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
4/15/2025 - GuruFocus
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025 ...
4/15/2025 - GuruFocus
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
4/15/2025 - Business Wire
Federated Hermes Inc. Has $6 Million Stake in Sage Therapeutics, Inc. (NASDAQ:SAGE)
4/14/2025 - MarketBeat
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Bought by Martingale Asset Management L P
4/14/2025 - Ticker Report
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick ...
4/12/2025 - GuruFocus
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE
4/12/2025 - Business Wire
SAGE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sage Therapeutics, Inc. ...
4/10/2025 - GuruFocus
SAGE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Sage Therapeutics, Inc. (NASDAQ: SAGE) and Encourages Long-Term SAGE Investors to Contact the Firm
4/10/2025 - Globe Newswire
Sage Therapeutics (SAGE, $6.92) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story
4/9/2025 - SeekingAlpha
Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag
4/9/2025 - Seeking Alpha - Long Ideas
Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag
4/9/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
-1.18
7-Day Total Return
4.08%
30-Day Total Return
-30.14%
60-Day Total Return
0.00%
90-Day Total Return
21.43%
Year to Date Total Return
8.51%
1-Year Total Return
70.00%
2-Year Total Return
-46.32%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 29, 2024 - $0.13
52-week High
Mar 13, 2025 - $0.39
Valuation
Market Cap
$14.68M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sagepotash.com
Phone Number
236 836 4182
Address
#605-899 West Pender Street
Vancouver, BC V6C 3B2
Country
Canada
Year Founded
2021
Business Description
Sector
Materials
Industry
Materials
Sage Potash Corp. engages in the acquisition, exploration, and development of mineral properties. It holds interest in the Sage Potash property located in the State of Utah. The company was... more